<DOC>
	<DOCNO>NCT00794014</DOCNO>
	<brief_summary>The purpose study establish optimal strategy side branch stenting coronary bifurcation lesion .</brief_summary>
	<brief_title>Optimal Strategy Side Branch Stenting Coronary Bifurcation Lesion</brief_title>
	<detailed_description>The purpose study evaluate relative efficacy safety conservative strategy compare aggressive strategy side branch stenting coronary bifurcation lesion .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Parent vessel diameter stenosis &gt; 75 % Parent vessel diameter stenosis 50 % 75 % angina and/or objective evidence ischemia noninvasive stress test The reference diameter branch 2.3 mm visual estimation Cardiogenic shock STelevation myocardial infarction within 48 hour symptom onset Left ventricular dysfunction ( echocardiographic leave ventricular ejection fraction &lt; 25 % ) Graft vessel Patients receive clopidogrel due condition Patients receive warfarin , cilostazol antiplatelet therapy Hypersensitivity clopidogrel aspirin Expectant survival less 1 year Women plan become pregnant Patients bleed diathesis ( coagulopathy , thrombocytopenia platelet dysfunction , Gastrointestinal genitourinary bleeding within prior 3 month ) Patients actively participate another drug device investigational study , complete primary endpoint followup period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
</DOC>